Medicinal Cannabis Drug Interactions: What to Raise With Your Doctor

Most conversations about medicinal cannabis focus on whether it works. The conversation that matters more for safety is a quieter one: what else you are already taking. Cannabinoids are processed by the same liver enzymes that handle a large share of common prescription medicines, which means the interaction question is not a fringe concern, it is routine clinical work. This article is general information current to 9 August 2026. It is not medical advice, it does not replace an individual assessment, and nothing here should be used to start, stop or change any medicine on your own.

Key takeaways

• Cannabidiol (CBD) and tetrahydrocannabinol (THC) are metabolised by cytochrome P450 liver enzymes, the same family that processes many widely prescribed medicines.
• CBD in particular can inhibit several of those enzymes, which can raise blood levels of other medicines even though the dose on the box has not changed.
• The classes that come up most often are anticoagulants, sedatives and central nervous system depressants, some antiepileptics, certain antidepressants, and some immunosuppressants.
• Interactions are usually manageable when the prescriber knows the full picture, and dangerous mainly when they do not.
• Bring a complete list of everything you take, including over-the-counter products, herbal preparations and supplements, because those count too.

Why cannabinoids interact with other medicines at all

Your liver breaks down most medicines using a family of enzymes called cytochrome P450, usually shortened to CYP. Two members of that family, CYP3A4 and CYP2C9, do a very large share of the work, and both are involved in processing cannabinoids.

Two things can happen from there.

The first is enzyme inhibition. CBD can inhibit several CYP enzymes, which slows the breakdown of other medicines that rely on them. If a medicine is cleared more slowly, more of it stays in circulation, and the effective exposure rises even though the prescribed dose is unchanged. For a medicine with a wide safety margin, that may not matter. For one with a narrow therapeutic window, where the gap between a therapeutic level and a toxic level is small, it can matter a great deal.

The second is additive effect, which has nothing to do with enzymes. If two substances both cause sedation, taking them together produces more sedation than either alone. This is the mechanism behind the most common real-world problem patients report, and it does not require any pharmacokinetic subtlety to explain.

The grapefruit comparison is genuinely useful here. Grapefruit juice inhibits CYP3A4, which is why some medicine labels warn against it. CBD acts on overlapping enzymes, and the warning exists for the same underlying reason.

The medicine classes that come up most often

Anticoagulants and antiplatelets

Warfarin is the standard example. It is metabolised substantially by CYP2C9, and case reports have described increases in INR, the measure of how long blood takes to clot, in patients using cannabinoids alongside it. A raised INR means a higher bleeding risk.

This is not a reason to avoid one or the other outright. It is a reason for the prescriber to know, so INR monitoring can be arranged around any change rather than after a problem appears.

Sedatives and central nervous system depressants

Benzodiazepines, the z-drugs used for sleep, opioid analgesics, and alcohol all depress the central nervous system. THC does too. Combining them can produce more drowsiness, slower reaction time, impaired coordination and, at the more serious end, respiratory depression when opioids are involved.

The practical consequences show up in ordinary life first: feeling much more affected than expected, difficulty waking, and impairment that persists into the next day. Falls are a genuine risk in older patients.

Antiepileptic medicines

The clearest documented interaction in this area is between CBD and clobazam. CBD raises levels of the active metabolite of clobazam, which increases sedation, and this interaction is well enough characterised that dose adjustment is a standard part of managing it. Interactions with valproate have also been described, including effects on liver enzyme readings.

Anyone taking antiepileptic medicine needs this managed by the prescriber who handles that treatment, not adjusted independently.

Antidepressants and other psychotropics

Several selective serotonin reuptake inhibitors and tricyclic antidepressants are processed by CYP enzymes that cannabinoids can affect. The additive effect matters here as well, since sedating antidepressants combined with THC can produce more sedation than expected. Some patients also report that anxiety symptoms change in either direction, which is worth reporting honestly at follow-up rather than waiting it out.

Immunosuppressants

Tacrolimus and similar medicines have narrow therapeutic windows and are heavily dependent on CYP3A4. Changes in blood level have real consequences for transplant patients, so this group needs specialist coordination rather than a general approach.

Cardiovascular medicines

Some calcium channel blockers, statins and antiarrhythmics rely on the same enzymes. THC can also raise heart rate, which is relevant if you already take medicine for a heart rhythm or blood pressure problem.

Supplements, herbal products and over-the-counter medicines count

Patients routinely leave these out of a medication list because they do not feel like medicines. Several are pharmacologically active and clinically relevant.

• St John's wort is a strong CYP3A4 inducer and can meaningfully lower levels of other medicines.
• Grapefruit juice inhibits CYP3A4, as above.
• Some sleep and calming supplements are sedating in their own right and stack with THC.
• Regular alcohol use changes both liver enzyme activity and the sedation picture.

If you take it, list it. The consultation cannot account for what it does not hear about.

What to bring to the consultation

The single most useful preparation is a complete and accurate list. Bring:

• Every prescribed medicine, with the dose and how often you take it, ideally from a pharmacy medication list or a photo of the boxes.
• Anything you take occasionally rather than daily, including painkillers and sleep aids.
• All over-the-counter products, vitamins, herbal preparations and supplements.
• Alcohol intake, honestly described.
• Recent pathology results, particularly liver function tests and INR if you take warfarin.
• Any past reaction or side effect to a medicine, and what it was.
• Your usual GP's details, so the doctor can write to them with your consent.

Patients often ask which details matter. Assume all of them do, and let the doctor decide what is relevant. There is more detail on getting the most out of an appointment in the guide to preparing for a follow-up appointment.

Warning signs to report promptly

Contact your doctor, or seek urgent care if the symptom is severe, if you notice:

• Unusual bruising or bleeding, including bleeding gums or blood in urine or stool.
• Sedation heavy enough that you cannot be roused normally, or that carries into the following day.
• Confusion, marked dizziness, or a fall.
• A racing or irregular heartbeat, chest pain, or fainting.
• Yellowing of the skin or eyes, which can indicate a liver problem.
• Any noticeable change in how well an existing medicine seems to be working.

In an emergency call 000. For medicine-specific questions, the Poisons Information Centre is available on 13 11 26 across Australia.

How prescribers manage this in practice

The usual approach is unremarkable and works well. The prescriber reviews the full medication list before anything is prescribed, identifies the medicines that share metabolic pathways, and decides whether the combination is appropriate at all. Where it is, monitoring is planned in advance, which may mean pathology at defined intervals, more frequent review early on, or specific things for you to watch and report.

Follow-up is where most of the safety value sits. The first review after starting anything new is when interaction effects surface, and it is the appointment patients are most likely to skip. Reviews at Medio are $59, and the prescribing doctor sees the same file rather than starting from scratch.

Two things are worth stating plainly. Do not stop or change a prescribed medicine to accommodate a new one without speaking to the prescriber, because abrupt cessation carries its own risks. And do not manage this by leaving something off the list, because the interaction still happens whether or not it was mentioned.

Frequently asked questions

Does CBD interact with medications even without THC?

Yes. CBD is the cannabinoid more strongly implicated in enzyme-mediated interactions, and the clobazam interaction is one of the better documented in the literature. A product having no THC does not remove the interaction question.

Can I drink alcohol while taking prescribed medicinal cannabis?

Alcohol and THC are both central nervous system depressants, so combining them increases impairment and sedation beyond what either produces alone. Raise it with your doctor rather than assuming a small amount is fine, particularly if you also take sedatives or opioids.

Will my doctor refuse to prescribe if I take other medicines?

Not usually. Most interactions are managed with monitoring and careful planning rather than avoidance. The assessment is about whether the combination can be managed safely for you specifically, and sometimes the answer is that it cannot, which the doctor will explain.

Should I tell my regular GP?

Yes, and with your consent the prescribing doctor can write to them directly. Keeping one practitioner with the full medication picture is the most effective single safeguard against an interaction being missed.

How long before an interaction shows up?

It varies. Additive sedation can appear on the first day. Enzyme-mediated changes in blood level generally build over days as the medicine accumulates, which is part of why an early review appointment matters.

References

1. Therapeutic Goods Administration. Medicinal cannabis: guidance for health practitioners. Australian Government. 2. Australian Government Department of Health and Aged Care. Guidance for the use of medicinal cannabis in Australia: patient information. 3. Medical Board of Australia. Good medical practice: a code of conduct for doctors in Australia. 4. Australian Medicines Handbook. Cannabinoids: interactions and precautions. 5. NPS MedicineWise. Cytochrome P450 enzymes and clinically significant drug interactions.